Patent details
301016
Product Name:
Combinatie van daunorubicine en cytarabine
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301016
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2768484
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
301016
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/18/1308
Marketing Authorization Type:
EEA
Marketing Authorization Date:
27/08/2018
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
25/10/2019
First Marketing Authorization date:
27/08/2018
Grant date:
16/04/2020
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
29/10/2019
SPC/SPC Extension Expiration Date:
26/08/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
25/10/2019
Name:
Jazz Pharmaceuticals Research LLC
Address:
3170 Porter Drive, Palo Alto, CA 94304, United States of America (US)
Agent
Name:
ir. H.A. Witmans c.s.
From:
25/10/2019
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
22/24
Publication date:
29/05/2024
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
17/20
Publication date:
22/04/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
44/19
Publication date:
30/10/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/10/2032
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
16/04/2020
Outgoing Correspondence
Decision grant
1
PDF
/3/6/7/5/7/0800475763/docs/301016_0_338954l504a.pdf
16/04/2020
SPC Documents
Certificate SPC
1
PDF
/3/6/7/5/7/0800475763/docs/301016_1_supplprotectioncertificate20200416104245686.pdf
15/04/2020
Incoming Correspondence Paper
Incoming Correspondence Paper
3
PDF
/3/6/7/5/7/0800475763/docs/301016_2_incomingcorrespondencepaper20200415122451321.pdf
15/04/2020
SPC Documents
Annex SPC
103
PDF
/3/6/7/5/7/0800475763/docs/301016_5_supplprotectioncertificate20200415122739333.pdf
05/03/2020
Outgoing Correspondence
Letter to applicant
1
PDF
/3/6/7/5/7/0800475763/docs/301016_7_327802l173.pdf
30/10/2019
Outgoing Correspondence
Confirmation receipt request
1
PDF
/3/6/7/5/7/0800475763/docs/301016_3_306594l174.pdf
25/10/2019
SPC Documents
Summary of the characteristics of the product
18
PDF
/3/6/7/5/7/0800475763/docs/301016_4_supplprotectioncertificate20191029012649277.pdf
25/10/2019
SPC Documents
Annex SPC
2
PDF
/3/6/7/5/7/0800475763/docs/301016_6_supplprotectioncertificate20191029012649351.pdf
25/10/2019
SPC Documents
Annex SPC
13
PDF
/3/6/7/5/7/0800475763/docs/301016_8_supplprotectioncertificate20191029012649428.pdf
25/10/2019
SPC Documents
Marketing Authorization SPC
3
PDF
/3/6/7/5/7/0800475763/docs/301016_9_supplprotectioncertificate20191029012649186.pdf
25/10/2019
Application Form
First filed application form
3
PDF
/3/6/7/5/7/0800475763/docs/301016_10_applicationform20191029012648935.pdf
25/10/2019
SPC Documents
Accompanying letter SPC
1
PDF
/3/6/7/5/7/0800475763/docs/301016_11_supplprotectioncertificate20200827102259930.pdf